Enzyme expands into Solana ecosystem with Neutral Trade

Press Releases are sponsored content and not a part of Finbold’s editorial content. For a full disclaimer, please . Crypto assets/products can be highly risky. Never invest unless you’re prepared to lose all the money you invest.

Paris, France, January 14th, 2025, Chainwire

Enzyme Finance, the leading EVM on-chain asset management infrastructure, is investing in Neutral Trade to extend its services into the Solana ecosystem.

This partnership will enable Enzyme to co-develop products with Neutral Trade, bringing Enzymes’ seamless and agile on-chain asset management solutions to the Solana ecosystem.

This initiative reflects Enzyme’s focus on advancing within the DeFi space and its role as an infrastructure for asset management. By entering the Solana ecosystem, Enzyme opens the door to an expansive network of developers, traders, and investors.

Neutral Trade aims to make advanced trading strategies available to a broader audience. Utilizing decentralized finance and smart contracts, the platform is designed to address traditional challenges such as know-your-customer requirements and high entry fees. Investors can access professional-grade strategies, including arbitrage and liquidity hedging, previously reserved for high-net-worth individuals and institutional players. The partnership with Neutral Trade expands Enzyme’s scope and supports its focus on offering accessible and efficient asset management tools.

The announcement follows a series of steps by Enzyme to enhance its global infrastructure. Recent developments include the addition of new product lines through the acquisition of Myso and the extension of existing offerings to new regions through a partnership with Neutral Trade.

Mona El Isa, Co-founder at Enzyme Finance commented: “With this collaboration, we’re entering one of the most dynamic ecosystems in DeFi. Our partnership with Neutral Trade allows us to integrate professional-grade trading strategies into our infrastructure, enabling a broader audience to benefit from the advantages of decentralized finance.

”Entering the Solana arena has been a goal for a long time and while this marks our first foray into this exciting area, we are looking to build innovative products to cement our position as the leading infrastructure of asset management.”

Jared, Founder of Neutral Trade, added: “Collaborating with Enzyme Finance accelerates our mission to democratize access to sophisticated trading strategies. Together, we can break down traditional financial barriers and empower a new generation of investors and fund managers.”

About Enzyme Finance:

Enzyme is the infrastructure for on-chain asset management. It is a non-custodial DeFi operating system designed to enable asset managers, treasury managers, DAOs, organizations, and institutional investors to create automated on-chain investment vaults. By utilizing smart contracts, Enzyme connects with dozens of DeFi protocols, allowing asset managers to develop composable strategies that harness the true potential of DeFi. Enzyme has been audited by Chain Security and has been on Mainnet since 2019.